The current price of LXRX is $1.48 — it has increased by 1.37% since the previous close. Data as of Nov 4, 2026.
LXRX is up 0.68% over the past week, down 18.68% over the past month and up 11.28% over the past year. The price is below its 200-day moving average of $1.89.
Of the 6 analysts covering Lexicon Pharmaceuticals, Inc., 1 rates it a strong buy, 3 rate it a buy and 2 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Lexicon Pharmaceuticals, Inc. has a market capitalization of $658.53M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Lexicon Pharmaceuticals, Inc. posted a loss of $0.06 per share against an estimate of -$0.05023, missing expectations by 19.45%. Upcoming reports are listed in the earnings calendar.
Lexicon Pharmaceuticals, Inc. reported revenue of $692K in its most recent quarter, which has decreased by 97.60% compared with the same quarter a year earlier. Analysts had expected $3.99M.
Lexicon Pharmaceuticals, Inc. has not paid any dividends over the past year.
In the latest trading session LXRX moved between $1.46 and $1.54, a range of 5.07% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Lexicon Pharmaceuticals, Inc. shows a sell rating today and a sell rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks LXRX has traded between $1.10 and $2.68. The current price is 44.78% below its 52-week high.
Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.